Cargando…

Prevalence of the epidermal growth factor receptor mutations in lung adenocarcinoma patients from the Middle East region

Lung cancer remains a major cause of cancer mortality with a 5-year survival in advanced stages around 4%. Platinum-based chemotherapy was routinely used as the standard of care in patients with advanced nonsmall cell lung cancer, but it is being progressively replaced by targeted molecular therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Tfayli, Arafat Hussein, Fakhri, Ghina Bassam, Al Assaad, Majd Sassine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611202/
https://www.ncbi.nlm.nih.gov/pubmed/31333766
http://dx.doi.org/10.4103/atm.ATM_344_18